an unfavorable trendp = 0.015
Survival analysis demonstrated that patients in the high Met-Index group had significantly shorter overall survival (OS, log-rank p = 0.005) and also exhibited an unfavorable trend for progression-free survival (PFS, log-rank p = 0.015) compared with those in the low Met-Index group (Fig. 5 B, top).